These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 29106390)
21. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Shima H; Kida K; Adachi S; Yamada A; Sugae S; Narui K; Miyagi Y; Nishi M; Ryo A; Murata S; Taniguchi H; Ichikawa Y; Ishikawa T; Endo I Breast Cancer Res Treat; 2018 Aug; 170(3):507-516. PubMed ID: 29693231 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway. Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015 [TBL] [Abstract][Full Text] [Related]
23. Pyruvate dehydrogenase kinase 1 is essential for transplantable mouse bone marrow hematopoietic stem cell and progenitor function. Halvarsson C; Eliasson P; Jönsson JI PLoS One; 2017; 12(2):e0171714. PubMed ID: 28182733 [TBL] [Abstract][Full Text] [Related]
24. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271 [TBL] [Abstract][Full Text] [Related]
25. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells. Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997 [TBL] [Abstract][Full Text] [Related]
26. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer. Lin A; Li C; Xing Z; Hu Q; Liang K; Han L; Wang C; Hawke DH; Wang S; Zhang Y; Wei Y; Ma G; Park PK; Zhou J; Zhou Y; Hu Z; Zhou Y; Marks JR; Liang H; Hung MC; Lin C; Yang L Nat Cell Biol; 2016 Feb; 18(2):213-24. PubMed ID: 26751287 [TBL] [Abstract][Full Text] [Related]
28. Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia. Almiron Bonnin DA; Havrda MC; Lee MC; Liu H; Zhang Z; Nguyen LN; Harrington LX; Hassanpour S; Cheng C; Israel MA Oncogene; 2018 Feb; 37(8):1107-1118. PubMed ID: 29155422 [TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53. Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250 [TBL] [Abstract][Full Text] [Related]
30. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783 [TBL] [Abstract][Full Text] [Related]
31. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α. Shi L; He C; Li Z; Wang Z; Zhang Q Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159 [TBL] [Abstract][Full Text] [Related]
32. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity. Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536 [TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA AK023096 interacts with hnRNP-K and contributes to the maintenance of self-renewal in bladder cancer stem-like cells. Zhao F; Qin S; Huang L; Ding L; Shi X; Zhong G Exp Cell Res; 2021 Dec; 409(2):112909. PubMed ID: 34742742 [TBL] [Abstract][Full Text] [Related]
34. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma. Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549 [TBL] [Abstract][Full Text] [Related]
35. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479 [TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells. Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511 [TBL] [Abstract][Full Text] [Related]
37. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions. Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732 [TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression. Shih JW; Chiang WF; Wu ATH; Wu MH; Wang LY; Yu YL; Hung YW; Wang WC; Chu CY; Hung CL; Changou CA; Yen Y; Kung HJ Nat Commun; 2017 Jun; 8():15874. PubMed ID: 28639619 [TBL] [Abstract][Full Text] [Related]
39. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis. Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]